MoO₂-Coated Photonic Crystal Fiber Biosensor for High-Sensitivity Detection of Cancer Cells

Cancer remains one of the most formidable challenges to human health, demanding detection methods that are not only precise but capable of identifying the disease in its earliest, most treatable stages. Traditional approaches, such as blood tests or imaging scans, often struggle to catch these early signs or require invasive procedures that can be difficult to perform repeatedly. In response, scientists have turned their attention to light-based technologies, specifically a field known as optical fiber sensing. These systems use thin strands of glass to carry light, which can interact with biological samples to reveal their properties. A particularly advanced version of this technology uses photonic crystal fibers, which are not solid like standard glass strands but are instead structured with tiny, repeating patterns of air holes. This unique architecture allows light to be guided in very specific ways, creating a sensitive environment where even the smallest changes in a nearby substance can be detected. When combined with a phenomenon called surface plasmon resonance—a process where light energy transfers to electrons on a metal surface to create a highly sensitive reaction—these fibers become powerful tools for spotting the subtle differences between healthy cells and cancerous ones.

Building on this foundation, a team of researchers from Shanxi Datong University and the Xinjiang Institute of Engineering has proposed a new sensor design that aims to improve the accuracy and stability of these detections. Instead of using the traditional gold or silver films that are common in such devices, the team coated their fiber with a layer of molybdenum dioxide. This material was chosen because it resists breaking down or reacting with the environment far better than gold or silver, ensuring the sensor remains reliable over time. The researchers constructed a fiber with a flat, polished side where this coating was applied, creating a D-shaped cross-section that allows the light inside the fiber to interact directly with the coating and any liquid sample placed against it. By carefully adjusting the size and position of the air holes within the fiber and the thickness of the molybdenum dioxide layer, the team simulated how the device would perform in a real-world scenario. Their calculations showed that this specific arrangement creates a strong interaction between the light and the surface, making the sensor exceptionally sensitive to changes in the refractive index, a property that varies between different types of cells.

The simulations revealed that the sensor could distinguish between six distinct types of cancer cells with remarkable precision. These included basal cells, cervical cancer cells known as HeLa, leukemia cells called Jurkat, PC-12 cells, triple-negative breast cancer cells known as MDA-MB-231, and another type of breast cancer cell called MCF-7. The device demonstrated a maximum sensitivity of 17,295.78 nanometers per refractive index unit, a figure that indicates how much the light's behavior shifts when it encounters a different type of cell. This level of sensitivity allows the sensor to detect minute differences that other methods might miss. Furthermore, the study showed that the sensor could resolve these differences with a precision ranging from 5.97 to 6.39 millionths of a refractive index unit. The researchers found that the thickness of the molybdenum dioxide layer played a critical role; a thinner coating of 25 nanometers yielded the highest sensitivity, while thicker layers reduced the device's ability to detect changes. Similarly, the position of the air holes relative to the fiber's core was adjusted to ensure the light remained focused on the sensing area, maximizing the interaction with the sample.

While the results are derived from computer simulations rather than physical experiments with live patients, the data suggests a clear path forward for this technology. The study indicates that by using molybdenum dioxide, it is possible to create a biosensor that is not only highly sensitive but also more durable than current options. The ability to differentiate between multiple types of cancer cells in a single setup points to a future where early screening could be faster and more accessible. The researchers conclude that this design holds significant promise for applications in bioanalysis and clinical diagnosis, offering a potential new tool for the early identification of cancer. By refining the structural parameters of the fiber and the properties of the coating, this approach could eventually lead to devices that help doctors identify the specific nature of a tumor with greater speed and accuracy, ultimately improving the chances for successful treatment.